Status:
COMPLETED
OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS
Lead Sponsor:
S.C.B. Medical College and Hospital
Conditions:
PCOS
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
This study is undertaken to compare the effects of treatment with commonly used OCP containing ethinylestradiol-cyproterone acetate and metformin in women with PCOS. Special attention will be paid to ...
Eligibility Criteria
Inclusion
- Women diagnosed with PCOS according to the Rotterdam criteria
Exclusion
- Current or previous use of oral contraceptives, glucocorticoids, antiandrogens, ovulation induction agents, antidiabetic and anti-obesity drugs or other hormonal drugs.
- Medical or surgical treatment of PCOS during the previous 3 months
- Presence of other endocrinopathies; except treated hypothyroidism on stable replacement doses of thyroid hormone
- Pregnancy, breastfeeding or desire for pregnancy during study interval (6 months)
- Inability to understand the proposal of the study precluding effective informed consent
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2018
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT03236740
Start Date
August 1 2017
End Date
March 15 2018
Last Update
March 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SCB Medical College
Cuttack, Odisha, India, 753007